(-)-alpha-phellandrene increases expression EXP 6480464 alpha phellandrene results in increased expression of HSPA2 mRNA CTD PMID:25075043 (R)-carnitine multiple interactions ISO Hspa2 (Rattus norvegicus) 6480464 Carnitine inhibits the reaction [Cadmium Chloride results in increased expression of HSPA2 protein] CTD PMID:22359436 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression EXP 6480464 o and p'-DDT results in decreased expression of HSPA2 mRNA CTD PMID:18204070 1,2-dimethylhydrazine increases expression ISO Hspa2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of HSPA2 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects binding EXP 6480464 Dinitrochlorobenzene binds to HSPA2 protein CTD PMID:32991956 17beta-estradiol multiple interactions ISO Hspa2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of HSPA2 mRNA CTD PMID:26496021 17beta-estradiol 3-benzoate decreases methylation ISO Hspa2 (Rattus norvegicus) 6480464 estradiol 3-benzoate results in decreased methylation of HSPA2 promoter CTD PMID:27415467 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of HSPA2 mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Hspa2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of HSPA2 mRNA more ... CTD PMID:16214954 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of HSPA2 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Hspa2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of HSPA2 mRNA CTD PMID:16891777 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Hspa2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of HSPA2 mRNA CTD PMID:21570461 and PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HSPA2 mRNA CTD PMID:12377990 more ... 2,6-dichloroindophenol multiple interactions EXP 6480464 [2 and 6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of HSPA2 mRNA CTD PMID:21034357 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Hspa2 (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of HSPA2 mRNA CTD PMID:22677475 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of HSPA2 mRNA CTD PMID:28628672 4-hydroxynon-2-enal decreases expression EXP 6480464 4-hydroxy-2-nonenal results in decreased expression of HSPA2 mRNA CTD PMID:12419474 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of HSPA2 mRNA CTD PMID:15958647 4-hydroxyphenyl retinamide increases expression ISO Hspa2 (Mus musculus) 6480464 Fenretinide results in increased expression of HSPA2 mRNA CTD PMID:28973697 4-phenylbutyric acid increases expression EXP 6480464 4-phenylbutyric acid results in increased expression of HSPA2 mRNA CTD PMID:14583596 5-fluorouracil increases expression EXP 6480464 Fluorouracil results in increased expression of HSPA2 mRNA CTD PMID:16101138 5-fluorouracil affects response to substance EXP 6480464 HSPA2 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 6-propyl-2-thiouracil increases expression ISO Hspa2 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of HSPA2 mRNA CTD PMID:24780913 acrylamide increases expression ISO Hspa2 (Rattus norvegicus) 6480464 Acrylamide results in increased expression of HSPA2 mRNA CTD PMID:28959563 afimoxifene decreases expression EXP 6480464 afimoxifene results in decreased expression of HSPA2 mRNA CTD PMID:19901195 aflatoxin B1 decreases expression ISO Hspa2 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of HSPA2 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of HSPA2 gene CTD PMID:28458013 alpha-phellandrene increases expression EXP 6480464 alpha phellandrene results in increased expression of HSPA2 mRNA CTD PMID:25075043 ammonium chloride affects expression ISO Hspa2 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of HSPA2 mRNA CTD PMID:16483693 amphibole asbestos increases expression EXP 6480464 Asbestos and Amphibole results in increased expression of HSPA2 protein CTD PMID:20855422 amphotericin B decreases expression EXP 6480464 Amphotericin B analog results in decreased expression of HSPA2 mRNA CTD PMID:28534445 antimycin A increases expression EXP 6480464 Antimycin A results in increased expression of HSPA2 mRNA CTD PMID:33512557 apigenin decreases expression ISO Hspa2 (Mus musculus) 6480464 Apigenin results in decreased expression of HSPA2 mRNA CTD PMID:22359648 aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of HSPA2 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO Hspa2 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of HSPA2 mRNA CTD PMID:23650126 arsane multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of HSPA2 mRNA CTD PMID:32525701 arsenic atom multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of HSPA2 mRNA CTD PMID:32525701 arsenite(3-) increases methylation EXP 6480464 arsenite results in increased methylation of HSPA2 promoter CTD PMID:23974009 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of HSPA2 protein CTD PMID:25419056 azoxystrobin decreases expression EXP 6480464 azoxystrobin results in decreased expression of HSPA2 mRNA CTD PMID:33512557 benzo[a]pyrene increases expression ISO Hspa2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of HSPA2 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of HSPA2 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of HSPA2 3' UTR and Benzo(a)pyrene results in increased methylation of HSPA2 exon CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of HSPA2 mRNA CTD PMID:20064835 more ... bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of HSPA2 mRNA CTD PMID:31163220 bisphenol A multiple interactions ISO Hspa2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of HSPA2 mRNA CTD PMID:26496021 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HSPA2 protein CTD PMID:34186270 bisphenol A increases expression ISO Hspa2 (Mus musculus) 6480464 bisphenol A results in increased expression of HSPA2 mRNA CTD PMID:32156529 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of HSPA2 mRNA CTD PMID:29275510 bisphenol A increases methylation ISO Hspa2 (Rattus norvegicus) 6480464 bisphenol A results in increased methylation of HSPA2 gene CTD PMID:28505145 bisphenol A decreases expression ISO Hspa2 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of HSPA2 mRNA CTD PMID:25181051 more ... Bisphenol B increases expression EXP 6480464 bisphenol B results in increased expression of HSPA2 protein CTD PMID:34186270 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of HSPA2 protein CTD PMID:34186270 cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSPA2 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO Hspa2 (Rattus norvegicus) 6480464 Carnitine inhibits the reaction [Cadmium Chloride results in increased expression of HSPA2 protein] CTD PMID:22359436 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSPA2 mRNA CTD PMID:35301059 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of HSPA2 mRNA CTD PMID:23828170 cadmium dichloride increases expression ISO Hspa2 (Rattus norvegicus) 6480464 Cadmium Chloride results in increased expression of HSPA2 protein CTD PMID:22359436 cannabidiol decreases expression EXP 6480464 Cannabidiol results in decreased expression of HSPA2 mRNA CTD PMID:33244087 cannabidiol increases expression EXP 6480464 Cannabidiol results in increased expression of HSPA2 mRNA CTD PMID:28025562 cannabidiol multiple interactions EXP 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of HSPA2 protein CTD PMID:34122009 carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of HSPA2 mRNA CTD PMID:25979313 carbofuran increases expression ISO Hspa2 (Rattus norvegicus) 6480464 Carbofuran results in increased expression of HSPA2 mRNA CTD PMID:20211217 carbon nanotube decreases expression ISO Hspa2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO Hspa2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 carbonyl cyanide p-trifluoromethoxyphenylhydrazone decreases expression EXP 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased expression of HSPA2 mRNA CTD PMID:16039398 chloroprene increases expression ISO Hspa2 (Mus musculus) 6480464 Chloroprene results in increased expression of HSPA2 mRNA CTD PMID:23125180 chlorpromazine decreases expression ISO Hspa2 (Rattus norvegicus) 6480464 Chlorpromazine results in decreased expression of HSPA2 mRNA and Chlorpromazine results in decreased expression of HSPA2 protein CTD PMID:36751017 chlorpromazine increases expression ISO Hspa2 (Rattus norvegicus) 6480464 Chlorpromazine results in increased expression of HSPA2 mRNA CTD PMID:36751017 choline multiple interactions ISO Hspa2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HSPA2 gene CTD PMID:20938992 chromium(6+) increases expression ISO Hspa2 (Rattus norvegicus) 6480464 chromium hexavalent ion results in increased expression of HSPA2 mRNA CTD PMID:30690063 chromium(6+) decreases expression EXP 6480464 chromium hexavalent ion results in decreased expression of HSPA2 mRNA CTD PMID:30690063 ciguatoxin CTX1B affects expression ISO Hspa2 (Mus musculus) 6480464 Ciguatoxins affects the expression of HSPA2 mRNA CTD PMID:18353800 cisplatin increases expression ISO Hspa2 (Rattus norvegicus) 6480464 Cisplatin results in increased expression of HSPA2 mRNA CTD PMID:22023808 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of HSPA2 mRNA CTD PMID:27392435 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of HSPA2 mRNA CTD PMID:33545341 copper atom multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which results in decreased expression of HSPA2 mRNA CTD PMID:30911355 copper(0) multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which results in decreased expression of HSPA2 mRNA CTD PMID:30911355 copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of HSPA2 mRNA CTD PMID:19549813 Cuprizon multiple interactions EXP 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of HSPA2 protein CTD PMID:34122009 cyclophosphamide affects response to substance EXP 6480464 HSPA2 protein affects the susceptibility to Cyclophosphamide CTD PMID:16217747 cyclophosphamide increases expression ISO Hspa2 (Rattus norvegicus) 6480464 Cyclophosphamide results in increased expression of HSPA2 mRNA CTD PMID:11599041 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of HSPA2 mRNA CTD PMID:20106945 and PMID:27989131 cyclosporin A decreases expression ISO Hspa2 (Mus musculus) 6480464 Cyclosporine results in decreased expression of HSPA2 mRNA CTD PMID:19770486 D-penicillamine increases expression EXP 6480464 Penicillamine results in increased expression of HSPA2 mRNA CTD PMID:22843330 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of HSPA2 mRNA CTD PMID:25047013 dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of HSPA2 mRNA CTD PMID:28628672 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of HSPA2 protein CTD PMID:25419056 dichloroacetic acid increases expression ISO Hspa2 (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of HSPA2 mRNA CTD PMID:28962523 dihydroxyacetone increases expression EXP 6480464 Dihydroxyacetone results in increased expression of HSPA2 mRNA CTD PMID:32506039 dinophysistoxin 1 increases expression EXP 6480464 dinophysistoxin 1 results in increased expression of HSPA2 mRNA CTD PMID:28939011 disodium selenite decreases expression EXP 6480464 Sodium Selenite results in decreased expression of HSPA2 mRNA CTD PMID:24383545 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO Hspa2 (Rattus norvegicus) 6480464 Doxorubicin results in increased expression of HSPA2 mRNA CTD PMID:20211217 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of HSPA2 mRNA CTD PMID:29803840 endosulfan increases expression ISO Hspa2 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of HSPA2 mRNA CTD PMID:31464424 entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA2 mRNA CTD PMID:27188386 entinostat increases expression EXP 6480464 entinostat results in increased expression of HSPA2 mRNA CTD PMID:26272509 and PMID:27188386 ethanol increases expression ISO Hspa2 (Mus musculus) 6480464 Ethanol results in increased expression of HSPA2 mRNA CTD PMID:19167417 ethanol affects expression ISO Hspa2 (Mus musculus) 6480464 Ethanol affects the expression of HSPA2 mRNA CTD PMID:30319688 etoposide affects response to substance EXP 6480464 HSPA2 protein affects the susceptibility to Etoposide CTD PMID:16217747 fenvalerate increases expression ISO Hspa2 (Rattus norvegicus) 6480464 fenvalerate results in increased expression of HSPA2 mRNA CTD PMID:30307764 folic acid multiple interactions ISO Hspa2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HSPA2 gene CTD PMID:20938992 fonofos increases methylation EXP 6480464 Fonofos results in increased methylation of HSPA2 promoter CTD PMID:22847954 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of HSPA2 mRNA CTD PMID:20655997 genistein increases expression EXP 6480464 Genistein results in increased expression of HSPA2 mRNA CTD PMID:20884965 gentamycin decreases expression ISO Hspa2 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of HSPA2 mRNA CTD PMID:33387578 geraniol decreases expression EXP 6480464 geraniol results in decreased expression of HSPA2 mRNA CTD PMID:27683099 gold atom decreases expression EXP 6480464 Gold analog results in decreased expression of HSPA2 mRNA CTD PMID:36057382 gold(0) decreases expression EXP 6480464 Gold analog results in decreased expression of HSPA2 mRNA CTD PMID:36057382 hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of HSPA2 mRNA CTD PMID:20044591 hydroquinone increases expression EXP 6480464 hydroquinone results in increased expression of HSPA2 mRNA CTD PMID:15452088 indirubin-3'-monoxime multiple interactions EXP 6480464 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in decreased expression of HSPA2 mRNA and [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HSPA2 mRNA CTD PMID:18958680 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of HSPA2 mRNA CTD PMID:28628672 iron dichloride increases expression EXP 6480464 ferrous chloride results in increased expression of HSPA2 mRNA CTD PMID:35984750 isoflavones multiple interactions ISO Hspa2 (Rattus norvegicus) 6480464 [ENNG co-treated with Isoflavones] results in increased expression of HSPA2 protein CTD PMID:22248470 isoprenaline increases expression ISO Hspa2 (Rattus norvegicus) 6480464 Isoproterenol results in increased expression of HSPA2 mRNA CTD PMID:20211217 and PMID:24286936 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of HSPA2 mRNA CTD PMID:24286936 ketamine increases expression ISO Hspa2 (Rattus norvegicus) 6480464 Ketamine results in increased expression of HSPA2 mRNA CTD PMID:20080153 L-methionine multiple interactions ISO Hspa2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HSPA2 gene CTD PMID:20938992 lead nitrate multiple interactions ISO Hspa2 (Rattus norvegicus) 6480464 Ashwagandha inhibits the reaction [lead nitrate results in increased expression of HSPA2 mRNA] CTD PMID:24987671 lead nitrate decreases expression ISO Hspa2 (Rattus norvegicus) 6480464 lead nitrate results in decreased expression of HSPA2 mRNA CTD PMID:21628963 lead nitrate increases expression ISO Hspa2 (Rattus norvegicus) 6480464 lead nitrate results in increased expression of HSPA2 mRNA CTD PMID:24987671 lipopolysaccharide multiple interactions EXP 6480464 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in decreased expression of HSPA2 mRNA more ... CTD PMID:18958680 more ... methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of HSPA2 mRNA CTD PMID:23649840 methylisothiazolinone increases expression EXP 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of HSPA2 mRNA CTD PMID:31629900 mitoxantrone affects response to substance EXP 6480464 HSPA2 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of HSPA2 mRNA CTD PMID:21527772 N-nitrosodiethylamine multiple interactions ISO Hspa2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of HSPA2 mRNA CTD PMID:20360939 nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of HSPA2 mRNA CTD PMID:24768652 and PMID:25583101 Nor-9-carboxy-delta9-THC multiple interactions EXP 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of HSPA2 gene CTD PMID:30521419 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of HSPA2 mRNA CTD PMID:29098329 ochratoxin A multiple interactions EXP 6480464 [ochratoxin A results in decreased acetylation of HSPA2 promoter] which results in decreased expression of HSPA2 mRNA CTD PMID:29098329 ochratoxin A decreases acetylation EXP 6480464 ochratoxin A results in decreased acetylation of HSPA2 promoter CTD PMID:29098329 okadaic acid increases expression EXP 6480464 Okadaic Acid results in increased expression of HSPA2 mRNA CTD PMID:28939011 oxaliplatin multiple interactions ISO Hspa2 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of HSPA2 mRNA CTD PMID:25729387 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of HSPA2 mRNA CTD PMID:21420995 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of HSPA2 mRNA CTD PMID:20883675 parathion increases methylation EXP 6480464 Parathion results in increased methylation of HSPA2 promoter CTD PMID:22847954 phenethyl caffeate multiple interactions ISO Hspa2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of HSPA2 mRNA CTD PMID:20360939 PhIP decreases expression ISO Hspa2 (Rattus norvegicus) 6480464 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in decreased expression of HSPA2 mRNA CTD PMID:15059925 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in decreased expression of HSPA2 mRNA and [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HSPA2 mRNA CTD PMID:18958680 picoxystrobin decreases expression EXP 6480464 picoxystrobin results in decreased expression of HSPA2 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO Hspa2 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of HSPA2 mRNA CTD PMID:19710929 potassium chromate decreases expression EXP 6480464 potassium chromate(VI) results in decreased expression of HSPA2 mRNA CTD PMID:22714537 propanal increases expression EXP 6480464 propionaldehyde results in increased expression of HSPA2 mRNA CTD PMID:26079696 quartz decreases expression EXP 6480464 Quartz results in decreased expression of HSPA2 mRNA and Quartz results in decreased expression of HSPA2 protein CTD PMID:27917503 quercetin affects binding EXP 6480464 Quercetin analog binds to HSPA2 protein CTD PMID:21798748 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of HSPA2 protein CTD PMID:19207037 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of HSPA2 mRNA CTD PMID:33512557 SB 431542 multiple interactions EXP 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 scopolamine increases expression ISO Hspa2 (Rattus norvegicus) 6480464 Scopolamine results in increased expression of HSPA2 mRNA CTD PMID:12818353 serpentine asbestos decreases expression EXP 6480464 Asbestos and Serpentine results in decreased expression of HSPA2 mRNA CTD PMID:29523930 silicon dioxide increases expression ISO Hspa2 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of HSPA2 mRNA CTD PMID:23221170 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of HSPA2 mRNA CTD PMID:25351596 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of HSPA2 protein CTD PMID:27917503 sodium arsenate increases expression ISO Hspa2 (Mus musculus) 6480464 sodium arsenate results in increased expression of HSPA2 mRNA CTD PMID:30953684 sodium arsenate multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of HSPA2 mRNA CTD PMID:32525701 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of HSPA2 mRNA CTD PMID:12760830 more ... sodium arsenite increases methylation ISO Hspa2 (Mus musculus) 6480464 sodium arsenite results in increased methylation of HSPA2 gene CTD PMID:24118411 sodium arsenite increases expression ISO Hspa2 (Mus musculus) 6480464 sodium arsenite results in increased expression of HSPA2 mRNA CTD PMID:15327774 sodium dichromate increases expression ISO Hspa2 (Rattus norvegicus) 6480464 sodium bichromate results in increased expression of HSPA2 mRNA CTD PMID:12325037 Soman increases expression ISO Hspa2 (Rattus norvegicus) 6480464 Soman results in increased expression of HSPA2 mRNA CTD PMID:19281266 streptozocin affects expression ISO Hspa2 (Mus musculus) 6480464 Streptozocin affects the expression of HSPA2 mRNA CTD PMID:18583417 sulforaphane decreases expression EXP 6480464 sulforaphane results in decreased expression of HSPA2 mRNA CTD PMID:31838189 sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of HSPA2 mRNA CTD PMID:31533062 tamoxifen increases expression ISO Hspa2 (Mus musculus) 6480464 Tamoxifen results in increased expression of HSPA2 mRNA CTD PMID:25123088 tamoxifen affects expression ISO Hspa2 (Mus musculus) 6480464 Tamoxifen affects the expression of HSPA2 mRNA CTD PMID:20937368 temozolomide decreases expression EXP 6480464 Temozolomide results in decreased expression of HSPA2 mRNA CTD PMID:31758290 terbufos increases methylation EXP 6480464 terbufos results in increased methylation of HSPA2 promoter CTD PMID:22847954 tert-butyl hydroperoxide decreases expression EXP 6480464 tert-Butylhydroperoxide results in decreased expression of HSPA2 mRNA CTD PMID:12419474 and PMID:15336504 tetrachloromethane affects expression ISO Hspa2 (Rattus norvegicus) 6480464 Carbon Tetrachloride affects the expression of HSPA2 mRNA CTD PMID:15963342 tetrachloromethane increases expression ISO Hspa2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of HSPA2 mRNA CTD PMID:31919559 theophylline increases expression EXP 6480464 Theophylline results in increased expression of HSPA2 mRNA CTD PMID:16083514 thioacetamide increases expression ISO Hspa2 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of HSPA2 mRNA CTD PMID:34492290 thiostrepton increases expression EXP 6480464 Thiostrepton results in increased expression of HSPA2 mRNA CTD PMID:22321511 topotecan multiple interactions ISO Hspa2 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of HSPA2 mRNA CTD PMID:25729387 topotecan affects response to substance EXP 6480464 HSPA2 protein affects the susceptibility to Topotecan CTD PMID:16217747 trichloroethene multiple interactions ISO Hspa2 (Mus musculus) 6480464 PPARA protein inhibits the reaction [Trichloroethylene results in decreased expression of HSPA2 mRNA] CTD PMID:15363585 trichloroethene increases expression ISO Hspa2 (Mus musculus) 6480464 Trichloroethylene results in increased expression of HSPA2 mRNA CTD PMID:25549359 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of HSPA2 mRNA CTD PMID:24935251 trichostatin A affects expression EXP 6480464 trichostatin A affects the expression of HSPA2 mRNA CTD PMID:28542535 trimellitic anhydride increases expression ISO Hspa2 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of HSPA2 mRNA CTD PMID:19042947 triphenylstannane decreases expression EXP 6480464 triphenyltin analog results in decreased expression of HSPA2 protein CTD PMID:31634547 Triptolide increases expression ISO Hspa2 (Rattus norvegicus) 6480464 triptolide results in increased expression of HSPA2 protein CTD PMID:32519852 triptonide increases expression ISO Hspa2 (Mus musculus) 6480464 triptonide results in increased expression of HSPA2 mRNA CTD PMID:33045310 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of HSPA2 mRNA CTD PMID:19140230 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of HSPA2 mRNA CTD PMID:19631733 tungsten decreases expression ISO Hspa2 (Mus musculus) 6480464 Tungsten results in decreased expression of HSPA2 mRNA CTD PMID:30912803 urethane increases expression EXP 6480464 Urethane results in increased expression of HSPA2 mRNA CTD PMID:28818685 usnic acid multiple interactions EXP 6480464 [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of HSPA2 mRNA CTD PMID:22777745 valproic acid decreases expression ISO Hspa2 (Mus musculus) 6480464 Valproic Acid results in decreased expression of HSPA2 mRNA CTD PMID:17292431 valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA2 mRNA CTD PMID:27188386 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of HSPA2 mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO Hspa2 (Mus musculus) 6480464 Valproic Acid results in increased expression of HSPA2 mRNA CTD PMID:19136453 and PMID:21427059 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of HSPA2 mRNA CTD PMID:25979313 vinclozolin affects expression ISO Hspa2 (Rattus norvegicus) 6480464 vinclozolin affects the expression of HSPA2 mRNA CTD PMID:19015723 zoledronic acid increases expression EXP 6480464 zoledronic acid results in increased expression of HSPA2 protein CTD PMID:28871336
